Author's response: Hepatitis B virus seromarkers clearance and risk of hepatocellular carcinoma: serious risks of misinterpretation.
The Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Jessica
J
Liu
The Genomics Research Center, Academia Sinica, Taipei, Taiwan Molecular and Genomic Epidemiology Center, China Medical University Hospital, Taichung, Taiwan Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan.
Hwai-I
HI
Yang
The Genomics Research Center, Academia Sinica, Taipei, Taiwan Graduate Institute of Epidemiology and Preventative Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Chien-Jen
CJ
Chen
D015415:Biomarkers / Q000097:blood*; D006528:Carcinoma, Hepatocellular / Q000503:physiopathology*; D004279:DNA, Viral / Q000097:blood*; D005260:Female; D006509:Hepatitis B / Q000097:blood*; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006513:Hepatitis B e Antigens / Q000097:blood*; D006801:Humans; D008113:Liver Neoplasms / Q000503:physiopathology*; D008297:Male
D015415:Biomarkers; D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens
Hepatitis B; Hepatocellular Carcinoma